Alejandro Ricart
Vice President, Oncology Clinical Development at TG Therapeutics, Inc. - New York, NY, US
Alejandro Ricart's Colleagues at TG Therapeutics, Inc.
Alejandro Ricart's Contact Details
HQ
(212) 554-4484
(212) 554-4484
Location
Company
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Alejandro Ricart's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Frequently Asked Questions about Alejandro Ricart
Alejandro Ricart currently works for TG Therapeutics, Inc..
Alejandro Ricart's role at TG Therapeutics, Inc. is Vice President, Oncology Clinical Development.
Alejandro Ricart's email address is ***@tgtxinc.com. To view Alejandro Ricart's full email address, please signup to ConnectPlex.
Alejandro Ricart works in the BioTech/Drugs industry.
Alejandro Ricart's colleagues at TG Therapeutics, Inc. are Jennifer PharmD, Bev Parson, Deedee Cornelius, Fred Ph.D., Amit Mahadevia, Pam Howley, Jeffrey PhD and others.
Alejandro Ricart's phone number is (212) 554-4484